EMEREN GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Emeren Group Ltd.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Emeren Group Ltd. (NYSE: SOL) to Shurya Vitra Ltd. Under the terms of the proposed transaction, shareholders of Emeren Group will receive $0.20 in cash per ordinary share or $2.00 in cash per American Depositary Share. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( [email protected] ) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nyse-sol/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn
View source version on businesswire.com:https://www.businesswire.com/news/home/20250620207625/en/
CONTACT: Kahn Swick & Foti, LLC
Lewis S. Kahn
[email protected]
855-768-1857
1100 Poydras St., Suite 960
New Orleans, LA 70163
KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA
INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL
SOURCE: Kahn Swick & Foti, LLC
Copyright Business Wire 2025.
PUB: 06/20/2025 08:51 PM/DISC: 06/20/2025 08:50 PM
http://www.businesswire.com/news/home/20250620207625/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Buffett Effect Still Holds as UnitedHealth Soars Through August
(Bloomberg) -- The Warren Buffett effect is proving true once again, spurring UnitedHealth Group Inc.'s reversal this month and giving the Dow Jones Industrial Average a push toward its first closing high since last year. Buffett's Berkshire Hathaway revealed last week that it bought a stake in the health insurer in the second quarter. UnitedHealth shares, which lost more than 50% from the start of 2025 through the end of July, have been on a tear this month, rising more than 20% in August alone and far outperforming any other company in the blue-chip index during that stretch. Why New York City Has a Fleet of New EVs From a Dead Carmaker Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone Trump Takes Second Swing at Cutting Housing Assistance for Immigrants A Photographer's Pipe Dream: Capturing New York's Vast Water System A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome The stock has added more than 300 points to the Dow in August, accounting for more than 40% of its monthly gain. It has been a welcome boost for the stock-price-weighted benchmark, which hit an intraday record on Tuesday but has yet to close at a new all-time high and has been trounced by other major equity indexes, like the S&P 500 and Nasdaq 100, this year. 'There wasn't a single piece of good news basically this whole year specific to UnitedHealth,' Morningstar analyst Julie Utterback said. 'So having a company like Berkshire Hathaway investing competitively in a managed firm that was attractively valued, that's really a nice vote of confidence.' NOTE: Aug. 15, UnitedHealth Surges After Buffett, Tepper Bet on Turnaround (2) The 'Buffett Effect' essentially refers to a stock market phenomenon where share prices rise when the legendary investor takes a stake and fall when he exits a position. In this case it's notable because until very recently UnitedHealth was the biggest drag on the Dow this year. Then it reversed direction and quickly went from worst to first. 'Really Tough Year' 'Investors in UnitedHealth have had a really tough year,' said Utterback, who tracks the stock's decline to early December, when former executive Brian Thompson was fatally shot outside an investor conference in New York. The stock is still down 40% in 2025 and is trading at a little more than $300. Utterback has a buy rating and $400 price target on the shares. Thompson's murder, which was a targeted attack aimed at UnitedHealth's leadership, helped send the Dow on its longest losing streak since the 1970s. At the same time, the insurer's stock fell from the biggest weight in the 30-member index to seventh. But since the Berkshire Hathaway stake was revealed after the market closed on Aug. 14, Wall Street has turned incrementally positive on UnitedHealth. And more broadly, investors are starting to see some momentum from the entire health-care sector. Jonathan Krinsky, chief market technician at BTIG, says he's 'sticking with health care for a more defensive posture' and because it's the best-performing sector in the market in August.A As for UnitedHealth, it may be more attractive as a longer-term position. 'If you can take a five-year view (on UnitedHealth), you likely will do well,' analysts at BofA Securities wrote in a note to clients on Monday that was subtitled 'Berkshire is in, should you be?' The bank raised also its price target on the stock to $325 from $290. And when it comes to dragging the Dow to a new closing high, the company still needs some help. 'The rest of the stocks still need to be able to rally,' said Matt Maley, chief market strategist at Miller Tabak + Co., though he added that removing the biggest drag on the index is a positive sign. 'The DJIA is something the individual investor watches more closely than the pros.' Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Survived Bankruptcy. Next Up: Cultural Relevance? Americans Are Getting Priced Out of Homeownership at Record Rates ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Top companies for women in NY: See who made Forbes' 2025 list
Over 70 New York companies are some of the best employers for women in the country, according to a recent study by business magazine Forbes and market research firm Statista. To compile their 2025 Best Employers for Women list, more than 140,000 women working for U.S. companies with at least 1,000 people were asked how likely they were to recommend their current and previous employers as well as employers they knew within the industry or through friends or family who worked there. The collected data and survey data from the past three years was then put into a scoring system. Greater weight was given to the more recent data and the responses from current employees. Seven hundred U.S. companies with the highest scores, including 75 in New York, made the final ranking. "These high-ranking companies, among others that have made our list, have likely learned that when women are represented in leadership — and across an organization — it can lead to material benefits not just for those women but for all employees," Forbes said. Here's where New York-based companies stand on the list. Which New York companies made it into the top 100 of Forbes' Best Employers for Women 2025 list? Forbes and Statista asked the participants to rate their current employers in areas such as pay equity, advancement opportunities, benefits for childcare or eldercare and the company's handling of incidents related to sexual misconduct and discrimination. Forbes' Best Employers for Women list for 2025 includes 75 New York-based companies from Long Island to Western New York. Here are the 10 that made it into the top 100: New York-Presbyterian Hospital, ranked No. 21 Goodwill Industries of Greater New York & Northern New Jersey, ranked No. 31 New York Life, ranked No. 32 JPMorganChase, ranked No. 56 New York Times, ranked No. 70 H&M - Hennes & Mauritz, ranked No. 73 American Express, ranked No. 80 Morgan Stanley, ranked No. 83 New York Power Authority, ranked No. 89 Roswell Park Comprehensive Cancer Center, ranked No. 94 How many other upstate NY companies made the list? Excellus BlueCross Blue Shield: Headquartered in Rochester and ranked No. 130 University of Rochester Medical Center: Located in Rochester and ranked No. 141 Upstate Medical University: Located in Syracuse and ranked No. 163 Wegmans Food Markets: Headquartered in Rochester and ranked No. 308 Corning: Headquartered in Corning and ranked No. 363 Constellation Brands: Headquartered in Victor and ranked No. 662 Vote now: What's the coolest thing made in New York? Forbes' top 10 employers for women NASA, headquartered in Washington, D.C. Johnson & Johnson, headquartered in New Jersey Kansas State University, located in Kansas Children's Healthcare of Atlanta, headquartered in Georgia Mutual of Omaha, headquartered in Nebraska hoag, headquartered in California BlueCross BlueShield of Tennessee, headquartered in Tennessee Nationwide Children's Hospital, located in Ohio Presbyterian SeniorCare, headquartered in Pennsylvania Fairway Independent Mortgage Corporation, headquartered in Wisconsin Emily Barnes reports on consumer-related issues for the USA TODAY Network's New York Connect Team, focusing on scam and recall-related topics. Follow her on X and Instagram @byemilybarnes. Get in touch at ebarnes@ This article originally appeared on Rochester Democrat and Chronicle: Top companies for women in NY: See who made Forbes' 2025 list Solve the daily Crossword
Forbes
6 minutes ago
- Forbes
What's Happening With Bullish Stock
Bullish (NYSE:BLSH) stock experienced a significant increase following its IPO last Wednesday. Although the listing was set at $37 per share, the stock surged to $118 during early trading before stabilizing around $63 after another sharp sell-off on Monday. The firm operates a cryptocurrency exchange designed for institutional investors, blending decentralized finance protocols with the security features of a centralized platform. Additionally, it owns Coin Desk, a prominent crypto news and data provider, which affords it media influence and the capacity to combine market intelligence with trading services. This advantage caters specifically to institutional investors. Bullish emphasizes compliance with regulations, licensing, and governance structures given its client base of institutional customers. So, is Bullish stock a worthwhile investment after the recent sell-off? Strong Growth Despite the company's distinct positioning, the stock still trades at around 95 times the revenues projected for 2024 following the recent sell-off, which isn't a low multiple even for a swiftly growing enterprise. Bullish's revenues soared to $97 million in 2024, up from $39 million in 2023, reflecting an over 140% year-on-year increase, with trading volumes reaching $250 billion in 2024 compared to $72.7 billion in 2022. Trading volumes in Q1 2025 saw another rise of 78%, and management anticipates profitability in Q2 with net income exceeding $100 million. Since its launch, the platform has registered more than $1.25 trillion in total trading volume and manages $2 billion in cryptocurrency assets, predominantly Bitcoin, with smaller portions allocated to Ethereum and stablecoins. The cryptocurrency markets remain volatile, with price fluctuations in Bitcoin and Ethereum significantly affecting performance. However, unlike exchanges focused on retail, Bullish caters to institutional investors, emphasizing Bitcoin and Ethereum trading. The interest from long-term investors with significant capital could render the company less susceptible to volatility compared to other brokers. Separately, will interface design software Figma stock decline to $40? A Smart Play On Institutional Crypto The investment rationale for Bullish stock is based on the long-term growth potential from institutional adoption of cryptocurrency. Unlike previous cryptocurrency cycles, which were predominantly influenced by retail traders, institutional interest is now growing due to increased regulatory clarity, the introduction of Bitcoin and Ethereum ETFs, and reinforced custody and compliance frameworks. The Trump administration's supportive attitude toward cryptocurrency and the enactment of favorable legislation could further amplify interest. Major financial managers, pension funds, endowments, and hedge funds are progressively incorporating digital assets into their investment strategies, which enhances liquidity and extends investment time horizons. For investors, this transition may warrant a higher valuation for Bullish, which is among the limited platforms specifically designed for these institutional clients. Nevertheless, there are also risks involved. Competition may intensify from entities such as Coinbase and Gemini. On the stock front, insider lock-ups set to expire in February 2026 could increase the supply of shares and exert downward pressure on prices. While BLSH stock shows promise, investing in individual stocks carries risks. Conversely, the Trefis High Quality (HQ) Portfolio, which comprises 30 stocks, has consistently outperformed the S&P 500 over the past four years. Why is that? As a collective, HQ Portfolio stocks have delivered superior returns with lower risk compared to the benchmark index; they have provided a smoother investment experience, as demonstrated in HQ Portfolio performance metrics.
